Coya Therapeutics (COYA) IPO deck
Coya Therapeutics is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (“Tregs”).
Coya Therapeutics is a clinical-stage biotechnology company focused on developing proprietary new therapies to enhance the function of regulatory T cells (“Tregs”).
%20IPO%20deck){kind=link}